je.st
news
Minerva Biotechnologies Granted Worldwide License To iPS Technology
2015-08-05 06:57:21| drugdiscoveryonline Home Page
Minerva Biotechnologies and iPS Academia Japan, Inc. announced recently that they have signed an agreement granting Minerva worldwide rights to use and commercialize the induced Pluripotent Stem (iPS) cells patent portfolio arising from the work of Professor Shinya Yamanaka, MD, Ph.D., who won the Nobel Prize for Medicine in 2012 for his discovery of four genes that can reprogram an adult’s cell to go back in time to become that person’s own stem cell
Tags: technology
license
worldwide
granted
Category:Biotechnology and Pharmaceuticals